A detailed history of Three Seasons Wealth, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Three Seasons Wealth, LLC holds 16,165 shares of BMY stock, worth $756,683. This represents 0.08% of its overall portfolio holdings.

Number of Shares
16,165
Holding current value
$756,683
% of portfolio
0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026

BUY
$42.6 - $49.08 $688,629 - $793,378
16,165 New
16,165 $872 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Three Seasons Wealth, LLC Portfolio

Follow Three Seasons Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Three Seasons Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Three Seasons Wealth, LLC with notifications on news.